New Zealand Doctor Urges Greater Use Of Tamiflu Despite Concern
This article was originally published in PharmAsia News
Executive Summary
A New Zealand expert is urging his government to use its stockpile of Roche's Tamiflu (oseltamivir) and begin vaccinating the populace despite increasing resistance to the drug by new flu strains. Influenza expert Lance Jennings said the drug is underused in New Zealand even though stockpiles of it exist, including the government's 855,000 doses put aside in 2005 to treat 21 percent of the population. He believes the nation's physicians should be educated about the advisability of administering the drug. (Click here for more
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.